Results
|
41821.
|
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. [electronic resource] by
- Lugthart, Sanne
- Gröschel, Stefan
- Beverloo, H Berna
- Kayser, Sabine
- Valk, Peter J M
- van Zelderen-Bhola, Shama Lydia
- Jan Ossenkoppele, Gert
- Vellenga, Edo
- van den Berg-de Ruiter, Eva
- Schanz, Urs
- Verhoef, Gregor
- Vandenberghe, Peter
- Ferrant, Augustin
- Köhne, Claus-Henning
- Pfreundschuh, Michael
- Horst, Heinz A
- Koller, Elisabeth
- von Lilienfeld-Toal, Marie
- Bentz, Martin
- Ganser, Arnold
- Schlegelberger, Brigitte
- Jotterand, Martine
- Krauter, Jürgen
- Pabst, Thomas
- Theobald, Matthias
- Schlenk, Richard F
- Delwel, Ruud
- Döhner, Konstanze
- Löwenberg, Bob
- Döhner, Hartmut
Producer: 20100906
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
41822.
|
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. [electronic resource] by
- Spitzer, T R
- McAfee, S
- Sackstein, R
- Colby, C
- Toh, H C
- Multani, P
- Saidman, S
- Weyouth, D W
- Preffer, F
- Poliquin, C
- Foley, A
- Cox, B
- Andrews, D
- Sachs, D H
- Sykes, M
Producer: 20001201
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 6
Availability: No items available.
|
|
41823.
|
|
|
41824.
|
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. [electronic resource] by
- Miyamoto, T
- Nagafuji, K
- Akashi, K
- Harada, M
- Kyo, T
- Akashi, T
- Takenaka, K
- Mizuno, S
- Gondo, H
- Okamura, T
- Dohy, H
- Niho, Y
Producer: 19960718
In:
Blood vol. 87
Availability: No items available.
|
|
41825.
|
|
|
41826.
|
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. [electronic resource] by
- Ferreri, Andrés J M
- Cwynarski, Kate
- Pulczynski, Elisa
- Ponzoni, Maurilio
- Deckert, Martina
- Politi, Letterio S
- Torri, Valter
- Fox, Christopher P
- Rosée, Paul La
- Schorb, Elisabeth
- Ambrosetti, Achille
- Roth, Alexander
- Hemmaway, Claire
- Ferrari, Angela
- Linton, Kim M
- Rudà, Roberta
- Binder, Mascha
- Pukrop, Tobias
- Balzarotti, Monica
- Fabbri, Alberto
- Johnson, Peter
- Gørløv, Jette Sønderskov
- Hess, Georg
- Panse, Jens
- Pisani, Francesco
- Tucci, Alessandra
- Stilgenbauer, Stephan
- Hertenstein, Bernd
- Keller, Ulrich
- Krause, Stefan W
- Levis, Alessandro
- Schmoll, Hans J
- Cavalli, Franco
- Finke, Jürgen
- Reni, Michele
- Zucca, Emanuele
- Illerhaus, Gerald
Producer: 20180126
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|
|
41827.
|
|
|
41828.
|
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. [electronic resource] by
- Spinelli, Orietta
- Peruta, Barbara
- Tosi, Manuela
- Guerini, Vittoria
- Salvi, Anna
- Zanotti, Maria Cristina
- Oldani, Elena
- Grassi, Anna
- Intermesoli, Tamara
- Micò, Caterina
- Rossi, Giuseppe
- Fabris, Pietro
- Lambertenghi-Deliliers, Giorgio
- Angelucci, Emanuele
- Barbui, Tiziano
- Bassan, Renato
- Rambaldi, Alessandro
Producer: 20070716
In:
Haematologica vol. 92
Availability: No items available.
|